INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that the company has received following details from shareholder : 1. Hitesh Khanna Jt. Anuj Khanna Folio No 17471, No. of shares 200, Certificate No -132121- 132122, Distinctive No- 81998701-81998900 2. Tarun Narula folio No6854, No of shares-200, Certificate Nos-44110-44111, Distinctive Nos 71830801- 71831000 INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that the Company has received intimation from following shareholders: 1. Daniel Massy Folio No-9151, No. of shares -200, Certificate No- 82000 to 82001, Distinctive No- 76353501 to 76353700 2. Bharat Bhushan, folio No-3638, No. of share -200, Certificate No-32182 to 32183, Distinctive No-70638001 to 70638200 3. Vivek Kapoor, Folio No-11521, No of shares-500, Certificate Nos-91826 to 91830, Distinctive no''s- 77336101- 77336600 INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Closure of Trading Window
It is to hereby informed that Trading Window for Trading window for dealing in shares of the company, will remain closed from effect of 1st Jusly,2024 till 48 hours after declaration of un-audited financial results for the quarter ending, 30th June, 2024. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform you that company has received information for loss of share certificate as follows: 1. Smita S Joshi- Folio No. 20490, No. Of Shares-100, Certificate No-13747, Distinctive No- 68794501-68794600 2. Pushpa Devi- Folio No. 23030, No of shares-500, Certificate Nos- 159470 to 159471, 60539, 92223 to 92224, Distinctive Nos- 84733601 to 84733800, 74207401 to 74207500, 77375801 to 77376000 INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby submit copy of the public notice of loss of share certificates, published on 5th June,2024, in the Financial Express Delhi edition. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
this is to inform you that the company has received intimation from the following shareholder: 1 Vinit Suri Jt. Neelam Suri Folio No- 642, No Of Shares-5000, Certificate No- 196162, Distinctive No- 54269702-54274701. 2. Vinit Suri Jt. Neelam Suri Folio No- 8338, No of Shares 3700, Certificate Nos. 196163, Distinctive Nos. 75840801-75844500. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Compliances-Reg.24(A)-Annual Secretarial Compliance
We hereby submit Annual secretarial compliance report from a practicing Company Secretary, for the year ended 31st March, 2024. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We hereby submits the copies of the public notice of the financial results, published on 18th May, 2024, in the Financial Express, all India edition, in English language and in Jansatta, Delhi edition in Hindi language. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Board Meeting Outcome for Approval Of Audited Financial Results & Recommendation Of Dividend For The Financial Year 2023-24
The Board of Directors of the Company at its meeting held on 17th May, 2024 i.e. today, interalia: 1. Approved audited financial statements for the year ended 31st March, 2024; and 2. Recommended a dividend @45% i.e. Rs. 4.50 per share for the financial year 2023-24. Details are given in the enclosed letter. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Audited Financial Results For The Quarter And Year Ended 31St March, 2024
this is to inform that the Board of directors of the company has, at its meeting held on Friday,17th May,2024 inter-alia: 1. approved the audited Financial Statements for the year ended 31st Marc,2024. 2 Recommended a dividend @45% i.e, Rs 4.5 per share for te financial year 2023-24 Details are given in the annexures.